Looking At ResMed's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on ResMed. Our analysis of options history for ResMed RMD revealed 8 unusual trades.

Delving into the details, we found 62% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $221,503, and 3 were calls, valued at $214,313.

Latest Startup Investment Opportunities:

What's The Price Target?

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $175.0 to $220.0 for ResMed during the past quarter.

Insights into Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ResMed's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ResMed's substantial trades, within a strike price spectrum from $175.0 to $220.0 over the preceding 30 days.

ResMed Option Activity Analysis: Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
RMD CALL SWEEP NEUTRAL 05/17/24 $220.00 $107.0K 9 155
RMD CALL SWEEP BULLISH 05/17/24 $220.00 $80.7K 9 1
RMD PUT SWEEP NEUTRAL 04/19/24 $175.00 $60.3K 618 144
RMD PUT SWEEP BULLISH 04/19/24 $175.00 $46.0K 618 234
RMD PUT SWEEP BULLISH 04/19/24 $175.00 $45.1K 618 510

About ResMed

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Following our analysis of the options activities associated with ResMed, we pivot to a closer look at the company's own performance.

Where Is ResMed Standing Right Now?

  • With a volume of 109,977, the price of RMD is up 2.65% at $189.16.
  • RSI indicators hint that the underlying stock may be approaching overbought.
  • Next earnings are expected to be released in 49 days.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ResMed options trades with real-time alerts from Benzinga Pro.

RMD Logo
RMDResMed Inc
$251.590.76%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
74.04
Growth
69.97
Quality
67.12
Value
22.64
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date of Trade
ticker
Put/Call
Strike Price
DTE
Sentiment

Comments
Loading...